These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 8625086
1. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form. Tamakoshi K, Kikkawa F, Nawa A, Ishikawa H, Mizuno K, Tamakoshi A, Yamagata S, Suganuma N, Tomoda Y. Cancer; 1995 Dec 15; 76(12):2565-71. PubMed ID: 8625086 [Abstract] [Full Text] [Related]
2. Different pattern of zymography between human gynecologic normal and malignant tissues. Tamakoshi K, Kikkawa F, Nawa A, Maeda O, Kawai M, Sugamuma N, Yamagata S, Tomoda Y. Am J Obstet Gynecol; 1994 Aug 15; 171(2):478-84. PubMed ID: 8059829 [Abstract] [Full Text] [Related]
3. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells]. Kikkawa F. Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug 15; 48(8):618-22. PubMed ID: 8808829 [Abstract] [Full Text] [Related]
4. Positive correlation between inhibitors of matrix metalloproteinase 1 and matrix metalloproteinases in malignant ovarian tumor tissues. Kikkawa F, Tamakoshi K, Nawa A, Shibata K, Yamagata S, Yamagata T, Suganuma N. Cancer Lett; 1997 Nov 25; 120(1):109-15. PubMed ID: 9570393 [Abstract] [Full Text] [Related]
5. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Di Nezza LA, Misajon A, Zhang J, Jobling T, Quinn MA, Ostör AG, Nie G, Lopata A, Salamonsen LA. Cancer; 2002 Mar 01; 94(5):1466-75. PubMed ID: 11920503 [Abstract] [Full Text] [Related]
6. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix. Nakagawa T, Kubota T, Kabuto M, Fujimoto N, Okada Y. J Neurooncol; 1996 Apr 01; 28(1):13-24. PubMed ID: 8740587 [Abstract] [Full Text] [Related]
7. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy. Riley SC, Leask R, Chard T, Wathen NC, Calder AA, Howe DC. Mol Hum Reprod; 1999 Apr 01; 5(4):376-81. PubMed ID: 10321811 [Abstract] [Full Text] [Related]
8. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, Zhang CL, Phillips BW, Zhang Y, Urbanski SJ. Am J Pathol; 1998 Dec 01; 153(6):1895-902. PubMed ID: 9846979 [Abstract] [Full Text] [Related]
9. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer. Gallegos NC, Smales C, Savage FJ, Hembry RM, Boulos PB. Surg Oncol; 1995 Dec 01; 4(2):111-9. PubMed ID: 7551259 [Abstract] [Full Text] [Related]
10. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface. Itoh Y, Ito A, Iwata K, Tanzawa K, Mori Y, Nagase H. J Biol Chem; 1998 Sep 18; 273(38):24360-7. PubMed ID: 9733724 [Abstract] [Full Text] [Related]
11. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer. Lengyel E, Schmalfeldt B, Konik E, Späthe K, Härting K, Fenn A, Berger U, Fridman R, Schmitt M, Prechtel D, Kuhn W. Gynecol Oncol; 2001 Aug 18; 82(2):291-8. PubMed ID: 11531282 [Abstract] [Full Text] [Related]
12. MMP and TIMP expression pattern in pleural effusions of different origins. Eickelberg O, Sommerfeld CO, Wyser C, Tamm M, Reichenberger F, Bardin PG, Solèr M, Roth M, Perruchoud AP. Am J Respir Crit Care Med; 1997 Dec 18; 156(6):1987-92. PubMed ID: 9412584 [Abstract] [Full Text] [Related]
13. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors. Terada T, Okada Y, Nakanuma Y. Hepatology; 1996 Jun 18; 23(6):1341-4. PubMed ID: 8675149 [Abstract] [Full Text] [Related]
14. Expression and activity of MMPS and their regulators in ovarian cancer. Naylor MS, Stamp GW, Davies BD, Balkwill FR. Int J Cancer; 1994 Jul 01; 58(1):50-6. PubMed ID: 8014015 [Abstract] [Full Text] [Related]
15. Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Marbaix E, Donnez J, Courtoy PJ, Eeckhout Y. Proc Natl Acad Sci U S A; 1992 Dec 15; 89(24):11789-93. PubMed ID: 1465400 [Abstract] [Full Text] [Related]
16. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Iwata H, Kobayashi S, Iwase H, Masaoka A, Fujimoto N, Okada Y. Jpn J Cancer Res; 1996 Jun 15; 87(6):602-11. PubMed ID: 8766524 [Abstract] [Full Text] [Related]
17. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Rosenberg GA, Estrada EY, Dencoff JE. Stroke; 1998 Oct 15; 29(10):2189-95. PubMed ID: 9756602 [Abstract] [Full Text] [Related]
18. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. Lampert K, Machein U, Machein MR, Conca W, Peter HH, Volk B. Am J Pathol; 1998 Aug 15; 153(2):429-37. PubMed ID: 9708803 [Abstract] [Full Text] [Related]
19. Matrix metalloproteinases-2 and -9, and tissue inhibitor of metalloproteinases-1 of the sheep placenta during the last third of gestation. Vagnoni KE, Zheng J, Magness RR. Placenta; 1998 Sep 15; 19(7):447-55. PubMed ID: 9778117 [Abstract] [Full Text] [Related]
20. Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin. von Bredow DC, Cress AE, Howard EW, Bowden GT, Nagle RB. Biochem J; 1998 May 01; 331 ( Pt 3)(Pt 3):965-72. PubMed ID: 9560329 [Abstract] [Full Text] [Related] Page: [Next] [New Search]